Status | Study |
Active, not recruiting |
Study Name: Can Fat Derived Stem Cells (SVF) be Used in the Treatment of Erectile Dysfunction After Prostatectomy Condition: Delayed Graft Function Date: 2014-06-03 Interventions: Other: adipose derived stem cells |
Completed |
Study Name: Prevention of Delayed Graft Function Using Eculizumab Therapy (PROTECT Study) Condition: Delayed Graft Function Date: 2014-05-15 Interventions: Drug: Eculizumab Eculizumab wi |
Recruiting |
Study Name: Belatacept for Renal Transplant Recipients With Delayed Graft Function Condition: Delayed Graft Function Date: 2014-04-21 Interventions: Drug: Belatacept Other Name: N |
Active, not recruiting |
Study Name: Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation Condition: Delayed Graft Function Kidney Transplantation Date: 2013-08-07 Interventions: Drug: Eculizumab Other Name: S |
Recruiting |
Study Name: A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys Condition: Delayed Graft Function Date: 2013-06-11 Interventions: Drug: Everolimus One of the im |
Recruiting |
Study Name: Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function Condition: Delayed Graft Function Kidney Transplant Date: 2013-04-16 Interventions: Drug: Belatacept Other Name: N |
Completed |
Study Name: Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function Condition: Delayed Graft Function Date: 2013-02-13 Interventions: Drug: OPN-305 Intravenous infu |
Active, not recruiting |
Study Name: Study on Delayed Graft Function Using Paired Kidneys Condition: Delayed Graft Function Date: 2012-03-21 Interventions: Drug: BB3 Daily intravenous ad |
Active, not recruiting |
Study Name: A Study of the Activity of Eculizumab for Prevention of Delayed Graft Function In Deceased Donor Kidney Transplant Condition: Delayed Function of Renal Transplant Date: 2011-07-25 Interventions: Drug: Eculizumab 1200 milligra |
Recruiting |
Study Name: Study to Improve Renal Function After Kidney Transplantation Condition: Delayed Graft Function Date: 2011-01-27 Interventions: Drug: BB3 intravenous drug |